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ABSTRACT
REV-ERBα (encoded by Nr1d1) is a nuclear receptor that is part of
the circadian clock mechanism and regulates metabolism and
inflammatory processes. The glucocorticoid receptor (GR, encoded
by Nr3c1) influences similar processes, but is not part of the
circadian clock, although glucocorticoid signaling affects resetting of
the circadian clock in peripheral tissues. Because of their similar
impact on physiological processes, we studied the interplay between
these two nuclear receptors. We found that REV-ERBα binds to the
C-terminal portion and GR to the N-terminal portion of HSP90α and
HSP90β, a chaperone responsible for the activation of proteins to
ensure survival of a cell. The presence of REV-ERBα influences the
stability and nuclear localization of GR by an unknown mechanism,
thereby affecting expression of GR target genes, such as IκBα
(Nfkbia) and alcohol dehydrogenase 1 (Adh1). Our findings highlight
an important interplay between two nuclear receptors that influence
the transcriptional potential of each other. This indicates that the
transcriptional landscape is strongly dependent on dynamic
processes at the protein level.
KEY WORDS: Nuclear receptor, Circadian clock, Glucocorticoid
receptor, REV-ERBα, HSP90
INTRODUCTION
In mammals, the circadian clock system regulates many
physiological, biochemical and behavioral processes with the
suprachiasmatic nuclei (SCN) as the main coordinating entity to
synchronize all cellular clocks in the body (Panda et al., 2002;
Reppert andWeaver, 2002). At the cellular level, the circadian clock
mechanism is controlled by genetically determined networks of
transcription–translation feedback loops involving clock genes,
including period (Per, for which there are three genes Per1–Per3),
cryptochrome 1 and 2 (Cry1 and Cry2), Bmal1 (also known as
Arntl) and Clock (Reppert and Weaver, 2001). The transcription
factors CLOCK and BMAL1 heterodimerize and activate the
expression of Per and Cry genes by binding to E-box elements in
their promoters. CRY and PER proteins form oligomers that are
transported from the cytoplasm to the nucleus, where they repress
their own transcription by inhibiting BMAL1–CLOCK activity.
BMAL1–CLOCK also induces the expression of the nuclear
receptor REV-ERBα (also known as NR1D1), which represses
the transcription of Bmal1 through direct binding to a REV-ERBα
response element (RORE) within the Bmal1 promoter (Buhr and
Takahashi, 2013). Rev-erbα (Nr1d1) is expressed in a variety of
tissue types, including brown fat, skeletal muscle and liver (Woldt
et al., 2013; Everett and Lazar, 2014). In addition to its action in the
circadian clock mechanism, REV-ERBα has been implicated in
adipogenesis (Kumar et al., 2010; Laitinen et al., 2015), muscle
differentiation (Downes et al., 1995), liver metabolism (Bugge
et al., 2012; Cho et al., 2012) and neurogenesis (Schnell et al.,
2014).
The glucocorticoid receptor (GR, encoded by Nr3c1) belongs to
the superfamily of steroid, thyroid and retinoid acid receptor proteins
that function as ligand-dependent transcription factors (Evans, 1988).
A common feature of GR is an obligate interaction with heat-shock
protein 90 (HSP90α and HSP90β, hereafter HSP90) before
hormone-dependent activation (Kirschke et al., 2014) and this
interaction is also known to be important in regulating GR stability
(Siriani et al., 2005; Sultana et al., 2013). Upon binding its cognate
ligand (glucocorticoids), GR undergoes conformational changes,
dissociates fromHSP90 binding, and subsequently translocates to the
nucleus and binds to conserved palindromic DNA sequences, the
glucocorticoid responsive element (GRE) (Berg, 1989). Depending
on the target gene, hormone-activated GR can stimulate or inhibit
gene transcription and direct binding of activated GR on GRE is the
main mechanism of regulation associated with glucocorticoid-
mediated transactivation (De Bosscher et al., 2003). For example,
GR exerts anti-inflammatory action in part by antagonizing nuclear
factor κB (NF-κB), which is known to activate genes coding for pro-
inflammatory cytokines such as tumor necrosis factor (TNF) (De
Bosscher et al., 2000) through the upregulation of the expression of
the NF-κB inhibitor IκB proteins (Scheinman et al., 1995; Almawi
and Melemedjian, 2002). Recent studies have also indicated that GR
can bind as a monomer or homodimer to target genes, depending on
absence or presence of glucocorticoids (Lim et al., 2015).
A role of REV-ERBα in inflammation has been reported (Gibbs
et al., 2012, 2014), and REV-ERBα appears to regulate NF-κB-
responsive genes in human vascular smooth muscle cells (Migita
et al., 2004). Overexpression of REV-ERBα upregulates
inflammatory markers, like IL-6 and COX-2, as well as nuclear
translocation of NF-κB (Migita et al., 2004), suggesting that REV-
ERBα might play an important role in the regulation of NF-κB
responsive genes. Among NF-κB controlled genes, TNF plays a
crucial role in alcohol liver diseases (Beier and McClain, 2010; Gao
et al., 2011). Ethanol increases NF-κB activation through reactive
oxygen species (ROS)-dependent pathways (Wang et al., 2015) and
production of TNF in hepatocytes is controlled by the
transcriptional activation of NF-κB through the degradation of
IκBα (Fan et al., 2004).
Given that REV-ERBαmight be involved in regulation of NF-κB
and that GR exerts anti-inflammatory functions through the
upregulation of the expression of IκBα, the correlation betweenReceived 11 April 2016; Accepted 17 September 2016
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REV-ERBα and GR is of particular interest. Therefore, we studied
the relationship between REV-ERBα and GR. Here, we show that
REV-ERBα and GR bind to HSP90 at different sites, affecting their
stability and subcellular localization by unknown mechanisms. As a
consequence the regulation of target genes is affected.
RESULTS
REV-ERBα influences the GR at the protein but not at the
transcript level
In order to test the possibility of whether GR and REV-ERBα
influence each other, we tested the expression of GR in Rev-erbα−/−
animals and compared it with the expression in wild-type (WT)
animals using liver extracts. Western blotting revealed that GR
protein was expressed in an almost constant manner over 1 day in
the liver and that this expression was strongly increased in Rev-
erbα−/− livers (Fig. 1A). Quantification of several experiments
indicated that this increase was statistically significant at the time
points zeitgebertime (ZT) 0, 12 and 18, where ZT0 is lights on and
ZT12 is lights off (Fig. 1B). This suggests that Rev-erbα affects GR
protein accumulation.
As a next step, we tested the possibility that REV-ERBα regulates
the expression of GR (Nr3c1) at the transcriptional level. Therefore,
we extracted mRNA from livers of wild-type and Rev-erbα−/−mice.
Quantitative real-time PCR (qRT-PCR) revealed that the level of
Nr3c1 mRNA was similar in wild-type and Rev-erbα−/− livers
(Fig. 1C), whereas Rev-erbα mRNAwas absent in the Rev-erbα−/−
animals (Fig. 1D). Given that the murine Nr3c1 promoter contains
REV-ERBα-binding sites (ROREs, Fig. 1E), we tested whether this
promoter cloned in front of a luciferase reporter gene (Nr3c1::luc)
was repressed by REV-ERBα in a transfection experiment using
NIH3T3 cells. We observed that increasing concentrations of Rev-
erbα expression vector did not lead to a reduction of luciferase
activity when using the Nr3c1::luc reporter in contrast to the
positive control Bmal1::luc reporter (Fig. 1F). This result indicates
that the Nr3c1 promoter is not directly regulated by the repressor
activity of REV-ERBα, which is consistent with the unaltered levels
of Nr3c1 mRNA in Rev-erbα−/− mice (Fig. 1C). Therefore, the
increase in GR protein in the liver of Rev-erbα−/− animals probably
occurs post-transcriptionally and/or post-translationally.
GR and REV-ERBα both bind to HSP90 affecting GR stability
Lack of the Rev-erbα gene leads to increased GR protein in the
liver (Fig. 1A). If REV-ERBα affected GR levels post-
transcriptionally, overexpression of Rev-erbα would lead to a
reduction of GR protein. In order to test this hypothesis, we
overexpressed differing amounts of REV-ERBα in NIH 3T3 cells.
We observed that increasing amounts of REV-ERBα protein lead
to a reduction of GR protein in these cells as revealed by western
blotting (Fig. 2A). One explanation for this might be that GR is less
stable in presence of excess REV-ERBα. Because HSP90
interacts with GR and thereby stabilizes it (Siriani et al., 2005;
Sultana et al., 2013), we hypothesized that REV-ERBα might
also bind to HSP90 and modulate GR stability. Therefore, we
immunoprecipitated HSP90 in presence of increasing amounts of
REV-ERBα, and tested the amounts of REV-ERBα and GR,
respectively, that were co-precipitated with HSP90 by western
blotting (Fig. 2B). Interestingly, increasing amounts of REV-
ERBα reduced the amount of GR that was co-precipitated with
HSP90 and increased the amount of REV-ERBα that was co-
precipitated with HSP90 in a dose-dependent manner (Fig. 2B).
Consistent with these observations, we found that the amount of
HSP90 immunoprecipitated GR was increased in liver extracts
from Rev-erbα−/− compared to wild-type animals (Fig. 2C).
Therefore, it is very likely that REV-ERBα modulates GR levels
by binding to HSP90. In order to test whether REV-ERBα binding
to HSP90 had an influence on the stability of GR, we treated NIH
3T3 cells with cycloheximide, a translation inhibitor, in presence
of endogenous REV-ERBα (Fig. 2D, top, left side) and in presence
of a plasmid leading to overexpression of REV-ERBα (Fig. 2D,
top, right side). We found that the half-life of GR protein was
reduced by overexpression of REV-ERBα and decreased from 10 h
to 5.2 h (Fig. 2D, middle panel), indicating that overexpression of
REV-ERBα affects the half-life of GR protein. Likewise, REV-
ERBα overexpression affected the half-life of HSP90, reducing it
from 8.7 h to 5.6 h (Fig. 2D, bottom panel). Hence, protein
stability of GR appears to be related to HSP90 levels, which are
directly or indirectly affected by REV-ERBα. We cannot exclude,
however, the possibility that indirect effects stemming from
changes in HSP90 levels can affect GR function through other
HSP90 client proteins.
Fig. 1. GRprotein, but notmRNA, is highlyexpressed inRev-Erbα−/−mice.
(A) Western blots of liver extracts from wild-type (WT) and Rev-erbα−/− mice
showing expression of GR and tubulin using their respective antibodies. Liver
whole-cell lysates were extracted from wild-type and Rev-erbα−/− mice every
6 h, beginning at Zeitgeber time (ZT) 0 for one 24-h cycle. (B) Quantification of
the GR signal normalized to tubulin (mean±s.d., n=3). **P<0.01 (two-way
ANOVA). (C) Quantification of glucocorticoid receptor (Nr3c1) mRNA in the
liver. Liver total RNAwas extracted from wild-type and Rev-erbα−/−mice every
6 h, beginning at ZT0 for one 24-h cycle, and Nr3c1 transcripts were quantified
(mean±s.d., n=3). (D) Quantification of Rev-erbα (Nr1d1) mRNA in the liver.
Liver total RNA was extracted from wild-type and Rev-erbα−/− mice every 6 h,
beginning at ZT0 for one 24-h cycle, and Rev-erbα transcripts were quantified
(mean±s.d., n=3). (E) Schematic representation of murineNr3c1 promoter with
its two REV-ERBα response elements (ROREs). (F) Luciferase assay of
Nr3c1::luc reporter constructs with Rev-erbα overexpression plasmids in
NIH3T3 cells. Bmal1::luc was used as a positive control (mean±s.d., n=3).
***P<0.001 (one-way ANOVA with Bonferroni post-test).
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REV-ERBα affects diurnal subcellular localization of GR
In a next step, we wanted to know how the absence of REV-ERBα
affects nuclear and cytoplasmic localization of GR in liver cells.
Immunohistochemistry on liver tissue from wild-type and
Rev-erbα−/− mice harvested at ZT8 and ZT20 revealed profound
alterations in the nuclear localization of GR that was dependent on
both the presence of REV-ERBα and the time of day (Figs 3 and 4).
At ZT8 REV-ERBα was strongly expressed in the nucleus of wild-
type liver and absent in Rev-erbα−/− liver whereas HSP90 was
expressed in both genotypes in the cytoplasm at both time points
ZT8 and ZT20 (Fig. 3). At ZT20 REV-ERBα was mainly in the
cytoplasm in wild-type (at reduced levels as compared to nuclear
REV-ERBα at ZT8 as determined by the quantification, see below
Fig. 5A) and absent in liver of Rev-erbα−/−mice (Fig. 3), illustrating
the diurnal pattern of REV-ERBα subcellular localization.
Interestingly, this pattern was inverted for GR in wild-type
animals (Fig. 4). GR was mainly cytoplasmic at ZT8 and nuclear
at ZT20. However, in Rev-erbα−/− mice, this diurnal pattern of
subcellular localization of GR was absent and GR was present at
both time points in the nucleus as well as in the cytoplasm (Fig. 4).
In order to quantify these observations, we performed a cytoplasmic
and a nuclear fractionation. REV-ERBαwas mainly nuclear at ZT8,
whereas GR was mainly cytoplasmic at this time point in wild-type
mice (Fig. 5A). The inverse was observed at ZT20 when REV-
ERBα was cytoplasmic and GR was nuclear. In Rev-erbα−/− mice,
GR was increased, especially in the nucleus, and the temporal
variations in both the nucleus and cytoplasm were absent (Fig. 5A),
which is consistent with the immunohistochemistry experiments
(Figs 3 and 4). These REV-ERBα-associated changes in nuclear
localization of GR were most likely not mediated by corticosterone,
because its levels were not significantly different between wild-type
and Rev-erbα−/− animals at ZT8 and ZT20 (Fig. 5B). Taken
together, these observations indicate that the presence of REV-
ERBα inversely correlates with a diurnal pattern in the subcellular
distribution of GR.
Diurnal interaction of GR and REV-ERBαwith HSP90 in liver
and sites of interaction on HSP90
In order to determine the timing of GR and REV-ERBα interaction
with HSP90 in the liver, we collected total protein extracts from liver
tissue around the clock from mice kept in a 12-h-light–12-h-dark
cycle. Western blotting revealed constant levels of HSP90 and GR
proteins in extracts from livers of wild-type mice (Fig. 6A, input).
REV-ERBα levels were diurnal with a peak around ZT4–ZT8
Fig. 2. REV-ERBα and GR compete with each other for
binding to HSP90, resulting in the destabilization of GR
protein. (A) Western blot of whole-cell extracts from NIH3T3
cells transfected with increasing amounts of expression
vector for Rev-erbα with indicated antibodies. The lower
panel shows the quantification of GR signal (mean±s.d.,
n=3). **P<0.01 (t-test). (B) Western blot (WB) of HSP90
immunoprecipitates (IP: HSP90) and whole-cell extracts
(Input) from NIH3T3 cells transfected with the expression
vector for Rev-erbα. The lower panel shows the
quantification of the GR and REV-ERBα signal in HSP90
immunoprecipitates normalized to that of HSP90 (mean±
s.d., n=3). *P<0.05 (one-way ANOVA with Bonferroni post-
test). (C) Western blot of HSP90 immunoprecipitates (IP:
HSP90) and whole-cell extracts (Input) from liver of wild-type
(WT) and Rev-erbα−/− mice (Rev−/−). The lower panel
shows the quantification of the GR and REV-ERBα signal in
HSP90 immunoprecipitates normalized to that of HSP90
(mean±s.d., n=3). **P<0.01, ***P<0.001 (t-test). (D)Western
blot of whole-cell extracts from NIH3T3 cells transfected with
expression vector for Rev-erbα and treated with
cycloheximide (CHX; 100 μg/ml). The middle panel shows
the quantification of GR signal. GR half-life with CHX alone
is 10 h (R2=0.84, n=4) and with CHX andRev-erbα it is 5.2 h
(R2=0.98, n=4). The lower panel shows the quantification of
HSP90 signal. HSP90 half-life with CHX alone is 8.7 h
(R2=0.87, n=4) and with CHX and Rev-erbα it is 5.6 h
(R2=0.99, n=4). Results are mean±s.d. The P-values given
on the figure were calculated with a two-way ANOVA test.
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(Fig. 6A, input). Immunoprecipitation of HSP90 co-precipitated GR
at ZT0 and ZT4 (Fig. 6A, right panel). REV-ERBα was co-
precipitated at ZT4, ZT8 and ZT12 with a peak at ZT8. These data
indicated a sequential interaction of GR and REV-ERBα with
HSP90 with an overlap at ZT4.
Because the interaction of the two nuclear receptors with HSP90
was sequential, we aimed to elucidate whether GR and REV-ERBα
bind to the same or different sites on the HSP90 protein. Three
different fragments of HSP90 (Fig. 6B, top scheme) fused at the
N-terminus to GST were used to determine interaction with the
ligand-binding domain (LBD) of GR and full-length REV-ERBα.
Three HSP90 constructs were overexpressed in bacteria and the
resulting proteins showed a size of about 55 kDa for GST-N,
70 kDa for GST-M and 40 kDa for GST-C. A pulldown assay
revealed interaction of the ligand-binding domain of GR (GR-LBD)
with GST-N and GST-M, whereas REV-ERBα interacted only with
GST-C (Fig. 6B). These results indicate that GR and REV-ERBα
interact at different sites with HSP90 andmost likely do not compete
for the same site.
Expression of GR target genes are affected byREV-ERBα and
vice versa
In order to evaluate the functional consequences of the interplay
between REV-ERBα and GR, we studied target genes of these two
transcription factors in dexamethasone-treated hepatocytes. GR
exerts anti-inflammatory action in part by antagonizing NF-κB,
which is known to activate genes coding for pro-inflammatory
cytokines, such as TNF (De Bosscher et al., 2000), through the
upregulation of the expression of IκBα (Scheinman et al., 1995;
Almawi and Melemedjian, 2002), a direct GR target (Fig. S1). To
examine the effects of REV-ERBα on the NF-κB signaling pathway,
we isolated primary hepatocytes at ZT8 and applied ethanol to these
cells (Fig. 7), which is known to induce inflammatory reactions. In
wild-type hepatocytes ethanol treatment led to an increase of
phosphorylated IκBα (p-IκBα) and a reduction of unphosphorylated
IκBα (Fig. 7A). As a consequence NF-κB translocated from the
cytoplasm into the nucleus (Fig. 7B). In contrast, unphosphorylated
IκBα accumulated in Rev-erbα−/− hepatocytes, probably as a
consequence of increased GR levels in these animals (Fig. 7A,B),
leading to reduced amounts of NF-κB in the nucleus. To test the
above observations, we measured the levels of TNF secretion. Upon
ethanol treatment TNF levels increased even in the presence of
scrambled short hairpin RNA (shRNA) molecules (Fig. 7C). In
contrast, ethanol did not induce TNF secretion in hepatocytes from
Rev-erbα−/− animals. However, knocking-down GR or IκBα
rescued, at least in part, ethanol-induced TNF secretion of Rev-
erbα−/− hepatocytes (Fig. 7C). This indicates that REV-ERBα
influences ethanol-induced TNF secretion through GR and IκBα in
hepatocytes. For this process, however, glucocorticoids, GR ligands,
are essential, because glucocorticoid-depleted Rev-erbα−/−
hepatocytes display similar levels of p-IκBα, IκBα and NF-κB
compared to wild-type heptaocytes (Fig. S2A; Fig. 2B). Therefore,
TNF can be normally induced in glucocorticoid-depleted Rev-erbα−/
− hepatocytes upon ethanol treatment (Fig. S2C).
Apparently, REV-ERBα affects GR targets, but does GR also
affect REV-ERBα targets? We isolated wild-type hepatocytes and
cultured them in presence of scrambled shRNA or GR shRNA. We
observed that GR shRNA knocked down GR at the mRNA (Fig. S3)
Fig. 3. Cellular distribution of REV-ERBα at different times of day.
Immunohistochemistry in the liver of wild-type and Rev-Erbα−/− mice at ZT8
and ZT20. Staining with antibodies recognizing HSP90 (a marker for
cytoplasm) and REV-ERBα are in green and red, respectively. Nuclei are
stained with DAPI (blue). The pink color indicates nuclear REV-ERBα and the
yellow color cytoplasmic REV-ERBα. Note the reversed cellular distribution of
REV-ERBα compared to GR (Fig. 4) in wild type. Scale bar: 50 µm.
Fig. 4. The change in cellular distribution of GR that is dependent on the
time of day is abolished in Rev-erbα−/−mice. Immunohistochemistry in the
liver of wild-type and Rev-Erbα−/− mice at ZT8 and ZT20. Staining with
antibodies recognizing HSP90 (marker for cytoplasm) andGR are in green and
red, respectively. Nuclei are stained with DAPI (blue). The pink color indicates
nuclear GR and the yellow color cytoplasmic GR. Scale bar: 50 µm.
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and the protein levels (Fig. 7D), which led to an increase in REV-
ERBα accompanied by a reduction in expression of its target
BMAL1 (Fig. S3; Fig. 7D). This is consistent with previous
findings (Preitner et al., 2002). Hence, GR can also affect the
expression of at least some REV-ERBα targets.
REV-ERBα andGRmodulate the diurnalmetabolic landscape
REV-ERBα has been strongly implicated in the regulation of
metabolism (Bugge et al., 2012; Cho et al., 2012). In order to test
whether metabolic changes observed in livers of Rev-erbα−/− mice
are related to GR, we compared genes changed in Rev-erbα−/−
animals with genes regulated by GR (Phuc Le et al., 2005). If the
hypothesis that REV-ERBα and GR influence expression of each
other’s target genes were correct, we would expect to be able to
identify changes in expression of direct GR targets in Rev-erbα−/−
animals.
In a first step, we performed RNA sequencing of wild-type and
Rev-erbα−/− livers at ZT8 and ZT20 and compared the data in
order to identify transcripts that are altered at ZT8 but not at
ZT20 (Fig. 8A). Because REV-ERBα is highly expressed at this
time point, the changes in REV-ERBα are substantial between
wild-type and Rev-erbα−/− animals, and, hence, the changes in
GR nuclear localization would also be substantial. We identified
846 genes altered in expression in Rev-erbα−/− livers (Fig. 8A).
We further analyzed up- or down-regulated genes between
Rev-erbα−/− and wild-type liver at ZT8 with a threshold of 1.5 or
Fig. 5. REV-ERBα and GR reciprocally influence their nuclear
localization. (A) Western blot of the cytoplasm and nuclear fraction of the liver
of wild-type (WT) and Rev-Erbα−/− (Rev−/−) mice at ZT8 and ZT20. The lower
panel shows the quantification of signals (mean±s.d., n=4). *P<0.05,
***P<0.001 (one-way ANOVA with Bonferroni post-test). (B) The levels of
corticosterone in the plasma of wild-type (black bars) and Rev-Erbα−/− (white
bars) mice revealed by ELISA (n=6, mean±s.d.).
Fig. 6. Diurnal interaction of GR and REV-ERBα with HSP90 in liver and
sites of interaction on HSP90. (A) Western blot of HSP90
immunoprecipitates (IP: HSP90) (right panel) and whole-cell extracts (Input)
from liver cells of wild-type mice. Livers were collected at ZT0, 4, 8, 12, 16 and
20. (B) Pulldown assays with an N-terminal (N, blue), middle (M, red) and
C-terminal (C, green) HSP90 fragment fused to GST that had been expressed
in bacteria by IPTG induction and purified with gluthatione sepharose resin.
The complex-resin–GST proteins were coimmunoprecipitated with either LBD-
GR or REV-ERBα, both fused to a His tag, that had been also expressed in
bacteria, purified using nickel resin and eluted using imidazole. The pulldown
was detected by western blotting. Anti-GST antibodies reveal a 55-kDa GST-N
protein, a 70-kDa GST-M protein and a 40-kDa GST-C protein. An anti-His tag
antibody reveals a 25-kDa GR-LBD and 75-kDa REV-ERBα protein in the
GST-N, GST-M and GST-C fractions, respectively.
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more. The resulting 25 genes were submitted to ontology
selection, and ordered according to biological process or
molecular function. We identified two genes involved in
immune system processes and 13 genes involved in metabolic
processes, including Bmal1, a clock gene directly regulated by
REV-ERBα (Preitner et al., 2002).
Then, we compared the 846 differentially expressed genes
between Rev-erbα−/− and wild-type at ZT8 (Fig. 8A) with genes
regulated by GR at around ZT4–ZT8 (Phuc Le et al., 2005).
From these 846 genes, we found 50 genes in common with a list
of genes altered in expression in livers after dexamethasone
injection (Fig. 8B, overlap yellow and red circles; Table S1,
green marked genes). Interestingly this list contained two genes
involved in metabolic processes that were more than 1.5 times
upregulated in Rev-erbα−/− liver (Cdkn1a and Ddc). From the
846 genes, 16 genes were also present in a list of genes derived
from a previous ChIP-on-Chip experiment at around ZT4–ZT8
(Phuc Le et al., 2005) using anti-GR antibodies, representing
differences in promoter-binding after dexamethasone injection
into livers (Fig. 8B, overlap red and green circles; Table S1,
blue marked genes). In common between the expression analysis
and the location analysis were eight genes that most likely
represent direct GR targets altered in Rev-erbα−/− livers
(Fig. 8B, overlap yellow, red and green circles; Table S1,
yellow marked genes).
From these eight potential GR target genes, we verified three
genes that displayed large changes by qRT-PCR, including alcohol
dehydrogenase 1 (Adh1), a proven direct target of GR (Edenberg
and Brown, 1992), glycine N-methyltransferase (Gnmt) and hepatic
lipase C (Lipc) (Fig. 8C). We observed significant differences in the
expression of these genes at ZT8 in Rev-erbα−/− compared to wild-
type livers. Interestingly, we identified Insig2a and IκBα (Nfkbia) in
the 50 genes representing the overlap of REV-ERBα- and GR-
dependent gene expression (Fig. 8B). We verified the difference in
gene expression of the bona fide REV-ERBα target gene Insig2a
(Le Martelot et al., 2009) and the GR target gene IκBα (Nfkbia)
Fig. 7. REV-ERBα and GR affect target genes of each
other in primary cultured hepatocytes. Western blots of
primary cultured hepatocytes of wild-type (WT) and Rev-
Erbα−/− (Rev−/−) mice. Cells were incubated with
dexamethasone (1 µM) for 24 h, and culture medium was
changed for one with or without 100 mM ethanol. (A) IκBα
(IκB) and p-IκBα (p-IκB) specific antibodies reveal an
increase in expression of IκBα in Rev-Erbα−/− cells and an
increase of p-IκBα in wild type after ethanol treatment (mean±
s.d., n=3). *P<0.05, **P<0.01, ***P<0.001 (one-way ANOVA
with Bonferroni post-test). (B) GR- and NF-κB-specific
antibodies reveal increased expression of GR in Rev-Erbα−/−
hepatocytes, increased nuclear NF-κB signal in wild type cells
and a decreased signal of NF-κB in Rev-Erbα−/− cells after
ethanol treatment (mean±s.d., n=3). *P<0.05, **P<0.01,
***P<0.001 (one-way ANOVA with Bonferroni post-test).
(C) ELISA of TNF in primary cultured hepatocytes from wild-
type andRev-Erbα−/−mice. Cells were treated with GRor IκBα
shRNA lentiviral particles. Scrambled shRNA lentiviral
particles (sc) were used as a negative control. At 24 h after
transduction, dexamethasone (1 µM) was added and cells
were incubated for 24 h, and then the culture medium was
changed for one with or without 100 mM ethanol (mean±s.d.,
n=3). *P<0.05, **P<0.01, ***P<0.001 (one-way ANOVA with
Bonferroni post-test). (D) Western blot of primary cultured
hepatocytes of wild-type mice. Cells were treated with GR
shRNA lentiviral particles. Scrambled shRNA lentiviral
particles were used as a negative control. The right panel
shows the quantification of signals (mean±s.d., n=3). *P<0.05,
**P<0.01 (t-test).
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(Deroo and Archer, 2001). Both genes were upregulated in
Rev-erbα−/− livers (Fig. 8D).
In order to test whether the verified genes in Fig. 8C,D are directly
regulated by GR, we performed chromatin immunoprecipitation
(ChIP) experiments. As control, we used the Per1 promoter, which
contains a GR response element (GRE) (Reddy et al., 2009). Probes
unrelated to theGRE for the Per1 promoter indicated the background
signal for the ChIP experiments (Fig. 8E, top middle panel). Using
specific probes flanking theGREwe observed a binding of GR to the
GRE that was dependent on the time of day element in the Per1
promoter in wild-type, with low or no binding at ZT8 and binding at
ZT20, but constant chromatin binding in liver derived from
Rev-erbα−/− mice (Fig. 8E, top left panel). Similar GR binding
was observed for Insig2, Adh1, Gnmt and Lipc (Fig. 8E). These
results indicate that these genes are regulated at least in part by
GR, suggesting that the increase in gene expression observed in
Rev-erbα−/− mice might stem from GR-related transcriptional
mechanisms and not necessarily from lack of REV-ERBα-
mediated transcriptional repression.
Taken together, these experiments support our hypothesis that
REV-ERBα and GR influence each other, affecting expression of
their respective target genes.
DISCUSSION
REV-ERBα and GR influence each other
GR (Nr3c1) and REV-ERBα (Nr1d1) both are nuclear receptors that
modulate similar physiological pathways, including metabolism
and inflammation (Tronche et al., 1998; Buckingham, 2006; Everett
and Lazar, 2014). We previously observed that Nr3c1 mRNA
expression is downregulated in the suprachiasmatic nuclei (SCN) of
Rev-erbα−/− mice compared to wild-type animals (Schnell et al.,
2014). This prompted us to test a potential relationship between
REV-ERBα and GR. Interestingly, we found that, in the liver, GR
protein in Rev-erbα−/− mice is upregulated compared to in wild
type (Fig. 1A,B). However, at the mRNA level, no differences in
Nr3c1 expression between the two genotypes were observed
(Fig. 1C). These findings indicate that GR in the liver is not
regulated in the same manner as in the SCN and that regulation in
Fig. 8. Gene expression changes in Rev-erbα−/− liver and
comparisonwith GR target genes. (A) Venn-diagram based on
the RNA sequencing analysis of Rev-erbα−/− and control (wild-
type, WT) livers at ZT8 (red) and ZT20 (blue). (B) Comparison of
the 846 genes altered at ZT8 (red) in Rev-Erbα−/− liver with
datasets fromPhuc Le et al. (2005) (yellowand green, ZT4–ZT8).
The yellow circle represents gene expression alterations in the
liver after dexamethasone treatment assessed by microarray.
The green circle represents genes detected by a ChIP-on-chip
assay using an antiserum raised against GR to reveal chromatin
bound by GR. (C) Verification of three of the eight genes in
common to all three evaluations: alcohol dehydrogenase 1
(Adh1), glycine N-methyltransferase (Gnmt), and hepatic lipase
C (Lipc). Values are mean±s.e.m., n=3. *P<0.05, **P<0.01 (two-
way ANOVA and Tukey’s post-test). (D) Verification of the bona
fide REV-ERBα target gene Insig2a and the GR target gene IκBα
(Nfkbia) (values are mean±s.e.m., n=3. *P<0.05, **P<0.01 (two-
way ANOVA and Tukey's post-test). (E) Chromatin
immunoprecipitation assay revealing the time-dependent
interaction of GR with the promoters of Per1, Insig2, Adh1,Gnmt
and Lipc. Values are mean±s.e.m., n=8, *P<0.05 (one-way
ANOVA with Bonferroni-post test).
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the liver most likely occurs at the post-transcriptional level
(Fig. 1F).
In NIH 3T3 cells, we observed an inverse relationship between
REV-ERBα and GR. The more REV-ERBα was expressed in the
cells the less GR was detected (Fig. 2A). Given that GR interacts
with heat-shock protein 90 (HSP90) before hormone-dependent
activation (Kirschke et al., 2014), we wondered whether REV-
ERBα would affect binding of GR to HSP90. We found that REV-
ERBα interacts with HSP90 in a dose-dependent manner (Fig. 2B)
influencing GR binding to HSP90 in an inverse fashion. This was
confirmed in liver tissue from Rev-erbα−/− mice (Fig. 2C). The
observation that the half-life of GR protein was shortened in
presence of the REV-ERBα expression plasmid corroborated the
above findings (Fig. 2D). Interestingly, however, REV-ERBα also
affected the half-life of HSP90 (Fig. 2D). Hence, stability of GR
could be mediated either directly or indirectly through modulation
of stability of HSP90 upon changes in the amount of REV-ERBα.
Taken together, we identified an inverse correlation between REV-
ERBα and GR, which is most likely related to binding of these two
nuclear receptors to HSP90.
Nuclear receptors regulate transcription and, hence, their
activity depends on their localization to the nucleus. Using
immunofluorescence and confocal microscopy we observed time-
dependent subcellular distribution changes in GR and REV-ERBα in
liver tissue (Figs 3, 4 and 5). In wild-type liver, GR was localized
predominantly to the cytoplasmat ZT8whereas itwas nuclear at ZT20
(Fig. 4). In contrast, REV-ERBα was distributed between cytoplasm
and nucleus in an inverse manner (Fig. 3). In the absence of REV-
ERBα the time-dependent subcellular distribution changes in GRwas
not observed anymore (Fig. 4), indicating that REV-ERBαmight play
a role in this process.We do not knowwhat the role of REV-ERBβ is,
but it is probably not strong, because it cannot compensate for the loss
of REV-ERBα. Our interpretation of the data is that REV-ERBα
influences the subcellular distribution of GR through interaction with
HSP90. However, we cannot exclude that REV-ERBα influences the
machinery for translocation of GR into the nucleus. Corticosterone
seems not to be a factor, though, because corticosterone levels in Rev-
erbα−/− mice are not different compared to in wild type (Fig. 5B),
as observed previously (Delezie et al., 2012).
Sequential interaction of REV-ERBα and GR at different sites
on HSP90
In order to investigate the temporal profile of REV-ERBα and GR
interaction with HSP90 we analyzed total liver extracts collected at
4-h intervals from ZT0–ZT20 of wild-type and Rev-erbα−/− mice
(Fig. 6A). We observed a sequential interaction of these two nuclear
receptors with HSP90 between ZT0 and ZT12 with an overlap at
ZT4. This indicates that the GR interaction with HSP90 disappeared
upon the emergence of REV-ERBα interaction. Because the binding
site of the two nuclear receptors to HSP90 appears not to be identical
(Fig. 6B), a direct competition for the same binding site on HSP90
can be excluded. Possibly structural changes of HSP90 due to REV-
ERBα binding might reduce the affinity of HSP90 for GR and
release it. This possibility is supported by the observation that REV-
ERBα protein levels start to increase at ZT4 with a maximum at ZT8
in liver tissue (Preitner et al., 2002), which coincides with the
observed binding to HSP90 (Fig. 6A). Because most of the REV-
ERBα protein appears to be nuclear at ZT8 (Fig. 3), the cytoplasmic
HSP90-bound form of this nuclear receptor is most likely a
differently modified or a truncated version. Evidence for a
modified form of REV-ERBα can be seen in our overexpression
experiment in Fig. 2D, where a double band of REV-ERBα protein
was detected (Fig. 2D, 0 h after CHX treatment). It is known that
REV-ERBα is phosphorylated and stabilized by GSK3β
phosphorylation at serine residues 55 and 59 (Yin et al., 2006),
and there might even be more modifications. Hence, post-
translational modifications are important for the stability and
might be important for the transport of REV-ERBα from the
cytoplasm to the nucleus. Variants of REV-ERBα stemming from
such processes are most likely dependent on the time of day, because
at the time when REV-ERBα is predominantly cytoplasmic (ZT20)
(Fig. 3) no interaction with HSP90 was observed (Fig. 6A).
Different forms of GR (splicing variants, translational initiation
variants or post-translational modification variants; reviewed in
Vandevyver et al., 2014) might also contribute to the inverse
subcellular distribution observed in comparison to REV-ERBα.
Evidence for this can be seen in Fig. 2C, where the input shows a
double band for GR, which disappears after immunoprecipitation
with HSP90 (Fig. 2C). This might affect REV-ERBα and its
interaction with HSP90 and its subsequent subcellular localization.
Taken together, it appears that the inverse subcellular localization we
observed between GR and REV-ERBα is mechanistically very
complex and not a simple competition between two nuclear receptors
for binding to HSP90. Given that HSP90 is a very abundant protein
in the cytoplasm, interaction with it is probably regulated by post-
translational modification of its binding partners.
REV-ERBα, GR and inflammation
Diurnal variation of inflammatory function has been described
(Castanon-Cervantes et al., 2010), but molecular mechanisms
mediating its gating are unknown. Disruption of the circadian
clock by deleting Bmal1 specifically in macrophages has been
shown to remove all temporal gating of endotoxin-induced
responses (Gibbs et al., 2012). This loss of circadian gating was
coincident with suppressed Rev-erbα expression. Given that REV-
ERBα has been reported to modulate expression of NF-κB-
responsive genes in humans (Migita et al., 2004) and GR exerts
anti-inflammatory action in part by antagonizing NF-κB through
upregulation of IκBα (Scheinman et al., 1995; Almawi and
Melemedjian, 2002), whose promoter contains GR-binding sites
(Lim et al., 2015), we treated primary cultures of hepatocytes from
control and Rev-erbα−/− mice with ethanol to activate this pathway
(Fig. 7, Fig. S1). We found that this signaling pathway is inhibited
in hepatocytes of Rev-erbα−/− mice, but knocking down GR or
IκBα led to an almost normal induction of this signaling pathway
as manifested by the induction of TNFα. Hence, REV-ERBα
appears to be a link between the clock and immune function, most
likely through its potential to interfere with the interaction of GR
with HSP90, thereby gating nuclear entry of GR to ZT20 by an
unknown and probably indirect mechanism (Fig. 4). This provides
a rational for the observation that in mice with a bronchiole-
specific deletion of Bmal1, circadian binding of GR at the Cxcl5
locus is disrupted (Gibbs et al., 2014). In these animals REV-
ERBα expression is strongly reduced, and the presence of GR in
the nucleus would not be gated anymore. Accordingly, Cxcl5
would not be rhythmically, but rather constantly expressed, which
has been observed in lung tissue of these animals (Gibbs et al.,
2014). Taken together, this indicates that gating of GR to the
nucleus involving REV-ERBα most likely does not only occur in
liver but in other tissues such as the lung as well.
REV-ERBα, GR and metabolism
Metabolism is affected in both Rev-erbα and GR liver-specific
knockout mice (Opherk et al., 2004; Bugge et al., 2012; Cho et al.,
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2012). Mice lacking GR in the liver display faster phase-resetting of
the liver clock upon restricted feeding (Le Minh et al., 2001), and
Rev-erbα−/− mice exhibit a reduction in food anticipatory behavior
(Delezie et al., 2012). This illustrates that metabolism is modulated
by these two nuclear receptors.
Our data support this view. For example, alcohol dehydrogenase
1 (Adh1) expression is altered in the liver of Rev-erbα−/− mice
(Fig. 8C) and is regulated by GR, as evidenced by ChIP (Fig. 8E),
illustrating the potential consequence of lack of REV-ERBα on GR
expression at ZT8. Similar effects were observed for glycine
N-methyltransferase (Gnmt) and hepatic lipase C (Lipc), enzymes
involved in liver detoxification and lipid metabolism, respectively.
Although these genes appear to be regulated by GR (Fig. 8E), the
pathways they are involved in are also altered in Rev-erbα−/− mice
(LeMartelot et al., 2009; Bugge et al., 2012; Cho et al., 2012). Most
interestingly, Insig2 an oxysterol sensor, that sequesters sterol-
regulatory-element-binding proteins to the endoplasmic reticulum
and thereby indirectly modulates fatty acid and cholestorol
metabolism, has been identified as a bona fide REV-ERBα target
(Le Martelot et al., 2009). Our data confirm the change of Insig2a
gene expression in Rev-erbα−/− mice (Fig. 8D) with the twist that
this gene can be regulated by GR, as evidenced by ChIP (Fig. 8E).
These results suggest a close relationship between REV-ERBα- and
GR-mediated transcriptional regulation.
In summary, we show in this study that REV-ERBα influences
the subcellular distribution of the GR protein by an unknown
mechanism. As a consequence these two nuclear receptors
influence the transcriptional potential of each other leading to a
temporal segregation of GR target gene expression. This illustrates
the complex cross-regulation between nuclear receptors, providing
an explanation for off-target effects of drugs modulating specific
nuclear receptor functions.
MATERIALS AND METHODS
Animals
Animal care and handling was performed in accordance with the guidelines of
the Schweizer Tierschutzgesetz (TSchG, SR455) and the declaration of
Helsinki authorized by the Office Veterinaire Cantonal de Fribourg.Rev-erba-
knockout mice (Preitner et al., 2002, 129/C57BL6 mixed background) were
obtained from heterozygous breeding pairs originally provided by Prof. Ueli
Schibler (Department of Molecular Biology, University of Geneva, Geneva).
Two- to four-month-old male mice were used for experiments and wild-type
mice served as controls. Animals were kept under 12 h light and 12 h dark
conditions with food and water ad libitum.
Cell culture
NIH3T3 mouse fibroblast cells (ATCCRCRL-1658™) were maintained
in Dulbecco’s modified Eagle’s medium (DMEM), containing 10%
fetal calf serum (FCS) and 100 U/ml penicillin-streptomycin at 37°C in a
humidified atmosphere containing 5% CO2. NIH3T3 cells were treated
with 100 µM cycloheximide after transfection containing either empty
vector or PSCT1-Rev-erbα. Cells were harvested 0, 2, 4 and 6 h after
treatment.
Quantitative real-time PCR
Total RNA was extracted from snap-frozen liver tissue using RNA-Bee
(AMS Biotechnology), according to the manufacturer’s instructions. Liver
RNA was precipitated in 4 M LiCl to remove glycogen, and was purified
further by phenol:chloroform extraction and ethanol precipitation.
Single-stranded DNA (ssDNA) complementary to the RNA starting from
hybridized random hexamer primers was synthesized with SuperScript II
(Life Technology Corporation) according to the manufacturer’s instructions.
SYBR green fluorescence-based qRT-PCR was performed for RNA
quantification (KAPA SYBR FAST Universal, KAPA Biosystems,
RotorGene 6000, Corbett Research). All RNA samples were normalized
to Gapdh. Primers are listed in Table S2.
Luciferase reporter assays and transfection
A 1756-bp fragment of the mouse Nr3c1 promoter region (−1750 to +6 bp
from the transcription start site containing RORE elements) was cloned into
the pGL3 basic vector (Promega) using the following primers: 5′-CGGT-
ACCTGAAGTCGTGTCCTTAC-3′ (sense primer) and 5′-CCTCGAGG-
TCTCCAAGAGAAACAC-3′ (anti-sense primer). Transfection and
luciferase reporter assays were performed with NIH3T3 cells according to
Schnell et al. (2014). The Bmal1 promoter region cloned into pGL3 were
used as positive controls.
Western blotting analysis
Protein of cultured cells and liver tissue was extracted using RIPA buffer
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1%
Triton X-100, 0.5% sodium deoxycholate containing protease and
phosphatase inhibitors). Protein samples (40 μg) were subjected to
electrophoresis on 10% SDS-polyacrylamide gels and transferred to a
nitrocellulose (Amersham Protran Supported 0.45 NC, GE healthcare).
After blocking with 0.5% dry milk in PBS-Tween 0.1%, the membranes
were probed with antibodies against GR (1:500, Santa Cruz Biotechnology,
sc-1004), HSP90α/β (F-8) (1:1000, Santa Cruz Biotechnology, sc-13119),
REV-ERBα (1:200, Santa Cruz Biotechnology, sc-100910), BMAL1
(1:500, Ripperger and Schibler, 2006), NF-κB p65 (1:200, Santa Cruz
Biotechnology, sc-109), IκBα (1:200, Santa Cruz Biotechnology, sc-371),
phosphorylated (p-)IκBα (1:200, Santa Cruz Biotechnology, sc-8404),
tubulin (1:1000, Abcam, ab 15246) or LAMINB1 (1:500, Santa Cruz
Biotechnology, sc-30264) overnight at 4°C. Anti-rabbit-IgG, mouse-IgG
and goat-IgG antibody conjugated to horseradish peroxidase (HPR) was
used as a secondary antibody. Detection of the immune complexes was
performed using Western Bright Quantum system (Advansta) and
quantification was done with the Quantity One analysis software (BioRad).
Pulldown assay with HSP90 fragments
GST-fused recombinant HSP90 proteins were expressed in an E. coli BL21
strain [plasmids: GST-Hsp90 N(9-236), GST-Hsp90M(272-617), and
GST-Hsp90 C(626-732), Addgene 22481, 22482 and 22483,
respectively]. Proteins were purified to homogeneity with glutathione–
agarose beads for 2 h at 4°C. The beads were then incubated overnight at
4°C with purified GR and REV-ERBα both containing a His-tag (GR-LBD:
pET15Avi6HT-Nr3c1 DNASU plasmid no. HsCD00651869; Rev-erbα:
pET15bxRev-erbα). Subsequently, elution with 10 mM reduced glutahione
took place for 15 min at room temperature. Elution was stopped by
adding Laemmli buffer and samples were loaded onto the gel after 10 min at
95°C.
Preparation of cytoplasm and nuclear extracts from primary
cultured hepatocytes
The isolated hepatocytes nuclear extracts were washed with PBS and then
were homogenized in ice-cold homogenization buffer (10 mM HEPES
pH 7.9, 1.5 mMMgCl2, 10 mMKCl, 1 mMDTT, 0.1 mM EDTA and 0.1%
NP40) containing protease inhibitor (1 μg/ml). The homogenates were
incubated on ice for 30 min and nuclei were collected by centrifugation at
800 g for 5 min at 4°C. Nuclei were resuspended in extraction buffer
(20 mM HEPES pH 7.9, 10% glycerol, 400 mM NaCl, 1.5 mM MgCl2,
0.1 mM EDTA, 1 mMDTT, and 0.1% NP40) containing protease inhibitor.
After incubation on ice for 1 h, cell debris and DNA was removed by
centrifugation at 21,000 g for 10 min at 4°C. Extracts were aliquoted and
stored at −80°C.
Co-immunoprecipitation
For co-immunoprecipitation experiments with cultured cells and mouse
whole-liver extracts, 400 μg of whole extracts were incubated with rotation
overnight at 4°C with the indicated antibody and captured with protein-A–
agarose beads (Roche Applied Science) for 4 h at 4°C. The beads were
washed four times with RIPA buffer. After washes, the samples were
4151
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 4143-4154 doi:10.1242/jcs.190959
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
resuspended in 4× SDS protein sample buffer (40% glycerol, 240 mM Tris-
HCl pH 6.8, 8% SDS, 0.04% Bromophenol Blue, 5% β-mercaptoethanol)
and subjected to SDS-PAGE.
Mouse hepatocyte isolation
Hepatocytes were isolated from livers of Rev-erbα−/− and wild-type mice
using collagenase perfusion with modifications. The inferior vena cava was
cannulated and the liver was first perfused in situ with a Hanks’ buffer salt
solution (HBSS), pH 7.4 (4 ml/min, 37°C for 10 min), followed by perfusion
with HBSS containing 1 mM Ca2+ and Mg2+ and 0.01% collagenase type 1
(Thermo Fisher Sientific), pH 7.4, for 10 min. The liver was removed and
then gently minced in HBSS containing 1 mM Ca2+ and Mg2+ and 0.01%
collagenase type 1, pH 7.4. The liver cell suspension was then filtered with
Falcon cell strainers (70 mm; Becton Dickinson, Bedford, MA) and
centrifuged at 50 g for 10 min. Cells were plated on a collagen-I-coated
plate (Thermo Fisher Sientific), (6×105 cells/well) in DMEM containing
10% FCS and 100 U/ml penicillin-streptomycin at 37°C in a humidified
atmosphere containing 5% CO2. After an initial 5-h attachment period,
cultures were washed with PBS and then fresh culture medium.
Immunohistochemistry
Animals used for the immunohistochemistry were killed at ZT8 and ZT20.
Brains were perfused with 0.9% NaCl and 4% paraformaldehyde (PFA).
Perfused brains were cryoprotected by 30% sucrose solution, and sectioned
(15 μm) using a cryostat. Sections chosen for staining were washed three
times with 1× TBS and 2× SSC (pH 7, 0.3 M NaCl/0.03 M tri-Na-citrate).
Antigen retrieval was performed with 50% formamide and 2× SSC by
heating to 65°C for 60 min. Later, sections werewashed in 2× SSC and in 1×
TBS pH 7.5 (0.1 M Tris-HCl, 0.15 MNaCl), before blocking them for 2 h in
10% normal donkey serum sterile (NDS, ab138579, abcam, UK), 0.1%
Triton X-100 and 1× TBS at room temperature. After the blocking, primary
anti-Rev-Erbα antibody (ab174309, abcam, 1:100), anti-GR (Santa Cruz
Biotechnology, sc-1004, 1:50) and anti-HSP90 antibody (Santa Cruz
Biotechnology, sc-13119, 1:50), diluted in 1% normal donkey serum
(NDS), 0.1% Triton X-100 and 1× TBS were added to the sections and
incubated 48 h at 4°C. Sections were washed with in 1× TBS and incubated
with the appropriate fluorescent secondary antibodies diluted 1:500 in 1%
NDS, 0.1% Triton X-100 and 1× TBS for 3 h at room temperature [Alexa
Fluor® 488-AffiniPure donkey anti-rabbit IgG (H+L), 711-545-152, and
Alexa Fluor® 647-AffiniPure donkey anti-mouse IgG (H+L), 715-605-150;
Jackson Immuno Research]. After washing with 1× TBS, nuclei were
counterstained with DAPI (300 nM) for 15 min. Finally, the tissue sections
werewashed again twice in 1× TBS andmounted on glass microscope slides.
Fluorescence images were taken by using a confocal microscope (Leica TCS
SP5), and images were taken with objective 20× a resolution of 1024×1024,
scan speed 200 Hz and z-stack of 1.5 μm through whole section with frame
average of 3. Images were processed with LAS AS software from LEICA.
Preparation of cytoplasm and nuclear extracts from liver
Small piece of frozen liver was homogenized in ice-cold homogenization
buffer (100 mM Tris-HCl, 10 mM DTT). The homogenates were incubated
on ice for 10 min and centrifuged at 2900 g for 5 min at 4°C. Pellets were
resuspended in 200 μl complete cytoplasm lysis buffer (10 mM EDTA,
10 mM Hepes, 5 mM NaF, 0.2 mM Na Vanadate, 2 mM DTT, and 0.2%
Triton X-100) containing protease inhibitor (Roche) and centrifuged at
2900 g for 5 min at 4°C. Supernatant were collected as cytoplasm extracts.
After three washes with complete cytoplasm lysis buffer, nuclei were
resuspended in 100 μl NDB buffer (20% glycerol, 20 mM Hepes, 0.2 mM
EDTA, 10 mM NaF, 0.4 mM Na Vanadate, 2 mM DTT and 100 mM KCl)
containing protease inhibitor and 100 μl NUN buffer (2 M urea, 600 mM
NaCl, 2% NP-40, and 50 mM Hepes) were added. After incubation on ice
for 30 min, cell debris and DNAwas removed by centrifugation at 15,700 g
for 30 min at 4°C. Supernatant was collected as for nuclear extracts.
Plasma corticosterone measurement
Under gaseous isoflourane anesthesia, blood samples were collected from
the tail vein at different time points (ZT8 and ZT20). Plasma was recovered
by centrifuging samples at 1500 g for 10 min in an Eppendorf centrifuge.
Plasma corticosterone levels were measured with the Corticosterone EIA kit
(ADI-900-097, Enzo Life Sciences) according to the manufacturer’s
instructions.
KnockdownofGRand IκBα, ethanol treatment andmeasurement
of TNF
At 24 h after seeding cells, shRNA lentiviral particles (GR; sc-35506-V,
IκBα; sc-29361-V, Santa Cruz Biotechnology) were used for knocking
down GR and IκBα according to the manufacturer’s instructions.
Knockdown efficiency was assessed at 48 h post transduction by western
blotting. Scrambled shRNA lentiviral particles (sc-108080, Santa Cruz
Biotechnology) was used as a negative control. At 24 h after transduction,
dexamethasone was added to a final concentration of 1 μM. After 24 h, the
culture mediumwas changed for onewith or without 100 mM ethanol. After
24 h, the medium was collected and the levels of TNF were measured with
the TNF alpha ELISA Kit (Thermo Fischer Scientific) according to the
manufacturer’s instructions. Cells werewashed twicewith phosphate buffer,
scraped and subjected to protein extraction.
RNA extraction and library construction
Liver samples were immediately flash frozen in liquidN2 and stored at−80°C.
RNA was extracted using NucleoSpin RNA (Machery-Nagel, Düren,
Germany) according to the instructions of the manufacturer. The quality of
the RNA samples was analyzed with a spectrophotometer, agarose gel
electrophoresis and reverse-transcription-PCR. Library construction starting
from the poly(A)-tail and multiplexing was performed according to the
instructions of the manufacturer (Illumina). The samples were organized
as follows: three replicas (1-WT, 2-WT, 3-WT) correspond to genotype WT
at ZT8; three replicas (4-Rev, 5-Rev, 6-Rev) correspond to genotype
Rev-erbα−/− at ZT8; three replicas (7-WT, 8-WT, 9-WT) correspond to
genotypeWTat ZT20; three replicas (10-Rev, 11-Rev, 12-Rev) correspond to
genotype Rev-erbα−/− at ZT20.
For the experiment, complementary DNA (cDNA) libraries were
barcoded using Illumina primers and loaded onto one lane of an
IlluminaHS2000 machine. cDNA libraries were diluted and loaded onto
each lane. The samples were sequenced for a maximum sequencing length
of 75 bp.
Analysis of RNA-Seq data sets
Sequences were aligned to the mouse genome (UCSC version mm10
database). Numbers of the sequences obtained for each library can be found
in Table S3. Sequences (fastq format) were mapped with Tophat (Trapnell
et al., 2009), uniquely mapped sequences from the output files (bam format)
were then used for further analysis, the percentage of the mapping obtained
for each sample can be found in Table S3. For all files, the reads were
counted with HTSeq-count using the following criteria:
samtools view sample.bam | htseq-count -m union -a 10 -s no -i
gene_name Mus_Musculus.gtf>sample_counts.txt.
Tests for differential expression between the samples were performed in R
software (R Core Team, 2014 http://www.R-project.org/) using the DESeq2
package (Version 1.6.3) (Love et al., 2014). A threshold on the corrected P
value was used to call for differentially expressed genes (P.adjust<0.05).
The RNA-seq data have been deposited in NCBI Gene Expression
Omnibus database under accession code GSE79087.
Pathway analysis
The analysis was performed using official web-based set of tools for
searching and browsing the Gene Ontology database AmiGO 2 (Carbon
et al., 2009) (http://amigo.geneontology.org/amigo). Analysis of GO data
was done using term enrichment analysis, finding significant shared GO
terms or parents of those GO terms to help discover what input genes might
be in common (Mi et al., 2013).
Chromatin immunoprecipitation
ChIP was performed as described previously (Ripperger and Schibler, 2006)
using an anti-GR antibody at a dilution of 1:25 (M-20, sc-1004, Santa Cruz
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Biotechnology). Binding sites for GR in the 5′-ends of target genes were
derived from a published ChIP sequencing experiment (GSM1446065 and
GSM1446066, Lim et al., 2015), comparing the binding of GR to mouse
liver chromatin at two different time points (6 am versus 6 pm). The probes
to detect the immunoprecipitated DNA fragments are listed in Table S4.
Statistical analysis
Statistical evaluation of all experiments was performed using GraphPad
Prism6 software. Depending on the type of data, either an unpaired t-test, or
one- or two-way ANOVA with Bonferroni or Tukey’s post-hoc test was
performed. Values were considered significantly different are highlighted
[P<0.05 (*), P<0.01 (**), or P<0.001 (***)].
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Supplemental Material: 
Supplemental Figures: 
 
 
Figure S1. Diagram of ethanol induced NF-kB signaling pathway linked to GR mediated 
transcriptional activation.  
REV-ERBα (REV, green hexagons) and GR (blue squares) interact with and compete for 
HSP90 (orange ovals). Upon ligand binding (red circles) GR enters the nucleus where it can 
activate  IκB transcription. IκB (red ovals) binds to NF-kB (yellow rounded rectangles) 
inhibiting its nuclear entry. Upon ethanol (EtOH) treatement cells activate reactive oxygen 
species (ROS, yellow oval) leading to activation of IκB-kinase (pink, rounded rectangle) which 
phosphorylates IκB. Phosphorylated IκB (p- IκB) liberates NF-kB, which can enter the nucleus 
and activate TNF-α transcription. 
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Figure S2 Rev-erbα does not affect TNF-α production in primary cultured hepatocytes in 
absence of dexamethasone. 
Western blot of primary cultured hepatocytes of wild-type and Rev-Erbα-/- mice incubated 
without dexamethasone and culture media were changed for one with or without 100 mM 
ethanol. (A) IκB and p- IκB specific antibodies (n = 3, *p<0.05, **p<0.01 mean ± SD). (B) GR 
and NF-kB specific antibodies (n = 3, *p<0.05, **p<0.01, or ***p<0.001 mean ± SD). (C) 
ELISA of TNF-α in primary cultured hepatocytes of wild-type and Rev-Erbα-/- mice. Cells 
were incubated without dexamethasone and culture media were changed for one with or without 
100 mM ethanol. 
 
J. Cell Sci. 129: doi:10.1242/jcs.190959: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
  
	  
 
Figure S3. GR affects Rev-erbα target gene at mRNA level. 
Quantification of GR, Rev-erbα, and Bmal1 mRNA in the primary cultured hepatocytes of wild-
type mice. Cells were treated with GR shRNA lentiviral particles. Scrambled shRNA lentiviral 
particles were used as a negative control (n = 3, *p<0.05, **p<0.01, or ***p<0.001 mean ± 
SD). 
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    Supplementary Tables: 
Supplementary Table S1. Genes from the analysis in Figure 8B. 
Green = 50 genes that overlap between Rev-erbα ko livers (Rev expression) and livers after 
dexamethasone injection (GR expression)  
Blue =  16 genes that overlap between Rev-erbα ko livers and a list of genes derived from a 
ChIP-on-Chip experiment (GR location) 
Yellow = 8 genes common to Rev expression, GR expression and GR location. 
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Supplementary Table S2. List of the primers used for quantitative PCR analysis. 
 
 
Gene Sense primer Anti-sense primer 
Gapdh CATGGCCTTCCGTGTTCCTA CCTGCTTCACCACCTTCTTGA 
Rev-erbα GAAGTGTCTCTCCGTTGGCATGTCT CGCTCTGCATCTCGGCAAGCAT 
Bmal1 CCAAGAAAGTATGGACACAGACAAA GCATTCTTGATCCTTCCTTGGT 
Nr3c1 CCCTGCATGTATGACCAA TGGCTCTTCAGACCTTCCTTA 
Insig2 CGTGACACTTTTTCCACCAG TACAACAGCCCAATCACAGC 
Lipc TAAACGCCATAACCCAGACC AGGTCACTGTGTTGCAAGGAG 
Gnmt GCTTTCAGGAGATGGCTTTG TTTGCAGTCTGGCAAGTGAG 
Adh1 TGCAGTTTTAGGCCATGAGG GCAAATCCTGCATTCTCCAC 
Ikba ACCTGGTTTCGCTCTTGTTG TGGAGATTTTCCAGGGTCAG 
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Supplementary Table S3. Analysis of RNA-Seq data sets 
 
Sample ID Number of 
sequences (fastq 
file) 
%CG Percentage of 
mapped sequences 
Mean Read 
Length 1_R1_WT_ZT8	   39206071	   48	   89.3%	   74	  2_R1_WT_ZT8	   36532696	   47	   83.4%	   74	  3_R1_WT_ZT8	   37468584	   46	   81.6%	   74	  4_R1_Rev_ZT8	   32698874	   46	   86.9%	   74	  5_R1_Rev_ZT8	   30319612	   47	   86.6%	   75	  6_R1_Rev_ZT8	   37990667	   47	   84.8%	   74	  7_R1_WT_ZT20	   36335511	   48	   90.2%	   74	  8_R1_WT_ZT20	   36377591	   47	   90.1%	   74	  9_R1_WT_ZT20	   34835184	   48	   90.9%	   75	  10_R1_Rev_ZT20	   39205228	   47	   90.4%	   75	  11_R1_Rev_ZT20	   40023217	   48	   91.9%	   74	  12_R1_Rev_ZT20	   34118413	   48	   92.2%	  	   74	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Supplementary Table S4. Primers for ChIP. 
 
(FAM: 6-fluorescin, BHQ1: black hole quencher 1): 
 
Adh_Gre 
FW: (5'-3'): CTT AGT CAT CAG GGA AAT GC  
RV: (5'-3'): CAT CTG CTG TCA CCT GAG TT 
TM: (5'-3'): FAM-CAC CAG TCA GAA TGG CTA AGA TCA AA-BHQ1 
 
Insig2_Gre 
FW: (5'-3'): CAA TCC TGC TGT CCT ACA TC 
RV: (5'-3'): AAA TAG AGA ACT CCC ATT GAG 
TM: (5'-3'): FAM-CCT GCC ATT GGT CAC CTT CC-BHQ1 
 
Lipc_Gre 
FW: (5'-3'): GCA GGC AAT AAT ACA GAG GT 
RV: (5'-3'): AGC CAA GCT CAT AGT TCA GA 
TM: (5'-3'): FAM-CAC CCA GCT GAC CTT TGG TCA-BHQ1 
 
Gnmt_Gre 
FW: (5'-3'): GTG TCC CTG CTC TCA CCT 
RV: (5'-3'): CGA TCC GCA CTT ATA ATC C 
TM: (5'-3'): FAM-CAG TCC CAC CTG GCC AAT G-BHQ1 
 
Per1_Gre 
FW: (5’-3’) ACT CGG GAG TCC ATG GGT TTG C 
RV: (5’-3’) CCG GCA CGA GGC CAG GAA T 
TM: (5’-3’) FAM-TCT GCG CTC CCT GTC TTC CTC CCT CCA-BHQ1 
 
Per1_con 
FW: (5’-3’) AGG CAC CAG AAA CCT CTT GT 
RV: (5’-3’) GGC GTA GAT CTG ACA GGC TA 
TM: (5’-3’) FAM-TGC CAG AGT CTC CAA AGT ATG CCC AC-BHQ1 
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